Overview
Mithula Sivasaravanaparan practices practicing medicine in Odense C, Denmark.
Their clinical expertise encompasses Alzheimer's Disease, Primary Amyloidosis, and Dementia.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mithula Sivasaravanaparan
Is Mithula Sivasaravanaparan a top-rated expert for Alzheimer's Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Mithula Sivasaravanaparan is classified as an Experienced expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mithula Sivasaravanaparan participate in research or clinical trials?
Yes. Mithula Sivasaravanaparan has published 8 articles and abstracts on conditions like Alzheimer's Disease. You can view a list of Mithula Sivasaravanaparan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alzheimer's DiseaseSivasaravanaparan isExperienced. Learn about Alzheimer's Disease.
- DementiaSivasaravanaparan isExperienced. Learn about Dementia.
- Primary AmyloidosisSivasaravanaparan isExperienced. Learn about Primary Amyloidosis.